WCCT expands clinical research services

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/amenic181)
(Image: iStock/amenic181)

Related tags: Medicine, Clinical trial

The global contract research organization (CRO) has announced an expanded clinical research service offering after merging with Medelis last year.

We believe there is a need in the marketplace for a midsized CRO with the specialization and research capabilities of a big CRO, but without the cost structure and typical headaches that can accompany working with a big CRO​,” David Fox, Executive Vice President, Client Services, told Outsourcing-Pharma.com.

Being a specialty CRO with phase I sites enables us to provide services to our sponsors from very early in the clinical development process right up until drug and/or device approval​,” explained Fox, adding that as a midsize CRO it is also able to place a “greater focus on PM and CRA retention​.”

The company’s expanded services include clinical research sites and full-service study management for early-stage clinical research and specialized therapies and medicines development.

Together, WCCT and Medelis are continuing our vision of becoming the global leader in the development of specialized medicines and therapies​,” said Fox.

Related news

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars